Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/220088
Title: | Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders |
Author: | González Díaz, Jairo M. Sánchez Dalmau, Bernardo Camós-Carreras, Anna Alba Arbalat, Salut Amoretti Guadall, Silvia Forte, Maria Florencia Serra Navarro, Maria Salmerón, Sergi Pérez Ramos, Anaid Vieta i Pascual, Eduard, 1963- Torrent Font, Carla Bernardo Arroyo, Miquel |
Keywords: | Esquizofrènia Malalties mentals Retina Tomografia Psicosi Schizophrenia Mental illness Retina Tomography Psychoses |
Issue Date: | 1-Mar-2025 |
Publisher: | Elsevier B.V. |
Abstract: | Emerging evidence suggests that retinal structural alterations are present in schizophrenia spectrum disorders (SSD), potentially reflecting broader neurodevelopmental and neurodegenerative processes. This cross-sectional study investigates retinal thickness and its clinical correlations in a sample of early-course SSD patients compared to healthy controls (HCs). One hundred-two eyes from 26 SSD cases and 25 age- and sex-matched HCs were included. Retinal structure was evaluated using Spectral-Domain Optical Coherence Tomography (SD-OCT), focusing on the peripapillary retinal nerve fiber layer (pRNFL), macular volume/thickness, and ganglion cell-inner plexiform layer (GCL+IPL) thickness. Although SSD cases showed increased peripapillary retinal nerve fiber layer (pRNFL) thickness in specific quadrants, most retinal parameters did not differ significantly between groups. Preliminary associations were observed between retinal measures, premorbid adjustment, DUP, and cognitive performance. These findings, while suggesting the potential of retinal imaging as a tool for early detection and monitoring of psychotic disorders, must be interpreted with caution. Further longitudinal and multimodal research is warranted to explore the association between these retinal changes and neuroinflammation, neurodegeneration, and overall brain health in SSD patients. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2024.12.006 |
It is part of: | European Neuropsychopharmacology, 2025, vol. 92, p. 38-47 |
URI: | https://hdl.handle.net/2445/220088 |
Related resource: | https://doi.org/10.1016/j.euroneuro.2024.12.006 |
ISSN: | 0924-977X |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Institut de Neurociències (UBNeuro)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
875399.pdf | 4.3 MB | Adobe PDF | View/Open Request a copy |
Document embargat fins el
28-2-2026
This item is licensed under a
Creative Commons License